<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>00841683121800</udiDi>
    <basicUdiDi>008416831386R-1FB</basicUdiDi>
    <tradeName>MyoD1 (EP212) Rabbit Monoclonal Primary Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>386R-18</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-28T02:20:02.611Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683121824</udiDi>
    <basicUdiDi>008416831395R-1FF</basicUdiDi>
    <tradeName>c-Myc (EP121) Rabbit Monoclonal Primary Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>395R-14</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-28T02:20:02.589Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683121831</udiDi>
    <basicUdiDi>008416831395R-1FF</basicUdiDi>
    <tradeName>c-Myc (EP121) Rabbit Monoclonal Primary Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>395R-15</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-28T02:20:02.577Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683121848</udiDi>
    <basicUdiDi>008416831395R-1FF</basicUdiDi>
    <tradeName>c-Myc (EP121) Rabbit Monoclonal Primary Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>395R-16</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-28T02:20:02.557Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683122135</udiDi>
    <basicUdiDi>008416831441R-1D9</basicUdiDi>
    <tradeName>NKX3.1 (EP356) Rabbit Monoclonal Primary Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>441R-14</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-28T02:20:02.541Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683122142</udiDi>
    <basicUdiDi>008416831441R-1D9</basicUdiDi>
    <tradeName>NKX3.1 (EP356) Rabbit Monoclonal Primary Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>441R-15</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-28T02:20:02.512Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683122159</udiDi>
    <basicUdiDi>008416831441R-1D9</basicUdiDi>
    <tradeName>NKX3.1 (EP356) Rabbit Monoclonal Primary Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>441R-16</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-28T02:20:02.489Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683122166</udiDi>
    <basicUdiDi>008416831441R-1D9</basicUdiDi>
    <tradeName>NKX3.1 (EP356) Rabbit Monoclonal Primary Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>441R-17</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-28T02:20:02.466Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683122173</udiDi>
    <basicUdiDi>008416831441R-1D9</basicUdiDi>
    <tradeName>NKX3.1 (EP356) Rabbit Monoclonal Primary Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>441R-18</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-28T02:20:02.445Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683122203</udiDi>
    <basicUdiDi>008416831104R-1BB</basicUdiDi>
    <tradeName>CD4 (SP35) Rabbit Monoclonal Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>104R-14</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-28T02:20:02.429Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683122210</udiDi>
    <basicUdiDi>008416831104R-1BB</basicUdiDi>
    <tradeName>CD4 (SP35) Rabbit Monoclonal Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>104R-15</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-28T02:20:02.412Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683122227</udiDi>
    <basicUdiDi>008416831104R-1BB</basicUdiDi>
    <tradeName>CD4 (SP35) Rabbit Monoclonal Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>104R-16</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-28T02:20:02.375Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683122289</udiDi>
    <basicUdiDi>008416831118R-1CJ</basicUdiDi>
    <tradeName>CD38 (SP149) Rabbit Monoclonal Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>118R-17</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-28T02:20:02.354Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683122296</udiDi>
    <basicUdiDi>008416831118R-1CJ</basicUdiDi>
    <tradeName>CD38 (SP149) Rabbit Monoclonal Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>118R-18</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-28T02:20:02.335Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683122715</udiDi>
    <basicUdiDi>008416831244R-1D4</basicUdiDi>
    <tradeName>DOG1 (SP31) Rabbit Monoclonal Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>244R-15</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-28T02:20:02.311Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683122722</udiDi>
    <basicUdiDi>008416831244R-1D4</basicUdiDi>
    <tradeName>DOG1 (SP31) Rabbit Monoclonal Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>244R-16</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-28T02:20:02.284Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683122739</udiDi>
    <basicUdiDi>008416831244R-1D4</basicUdiDi>
    <tradeName>DOG1 (SP31) Rabbit Monoclonal Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>244R-18</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-28T02:20:02.255Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683122920</udiDi>
    <basicUdiDi>008416831101R-1AN</basicUdiDi>
    <tradeName>CD1a (EP3622) Rabbit Monoclonal Primary Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>101R-14</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-28T02:20:02.233Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683122937</udiDi>
    <basicUdiDi>008416831101R-1AN</basicUdiDi>
    <tradeName>CD1a (EP3622) Rabbit Monoclonal Primary Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>101R-15</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-28T02:20:02.210Z</lastUpdated>
  </row>
  <row>
    <udiDi>00841683122944</udiDi>
    <basicUdiDi>008416831101R-1AN</basicUdiDi>
    <tradeName>CD1a (EP3622) Rabbit Monoclonal Primary Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>101R-16</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-28T02:20:02.190Z</lastUpdated>
  </row>
</eudamedExport>